Evotec Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus. Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019. Evotec, Celmatix Partner on Women's Reproductive Health Drug Discovery About a year ago, New York City-based Celmatix launched a division to discover therapeutics for women's health indications including reproductive disorders. Evotec Acquires iPSC Drug-Discovery Assets From Ncardia The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells. Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery Evotec will access Indivumed's IndivuType multi-omics cancer database to discover and develop new precision therapeutics for colorectal cancer. Sep 6, 2018 Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery Aug 27, 2018 Centogene, Evotec Forge Drug-Discovery Alliance May 2, 2018 Evotec Licenses CRISPR-Cas9 Technology From ERS Dec 4, 2017 Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling Aug 4, 2017 In Brief This Week: Thermo Fisher, Grifols, MDxHealth, Exosome Diagnostics, and More Nov 30, 2016 Evotec Inks Deal to Offer Merck KGaA Gene Editing, Silencing Technologies Jul 6, 2016 Evotec Licenses CRISPR Tech From Broad Institute, Harvard Sep 11, 2014 CHDI Extends Evotec Huntington's Collaboration Through 2017 Apr 25, 2014 Evotec-Roche Deal Indicates Adoption of Mass Spec, Hi-Res Instrumentation for Clinical Protein Quant Premium Sep 12, 2013 Evotec, HSCI Ink ALS Deal Sep 6, 2013 String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms Premium Aug 21, 2013 Evotec, Jain Foundation Expand Muscular Dystrophy Collaboration Jul 9, 2013 Evotec, Dow AgroSciences Enter Proteomics Service Deal Jan 4, 2013 Evotec Inks Deal with Apeiron to Use Chemical Proteomics in Cancer Drug Development Premium Jan 3, 2013 Evotec Buys Cell-based Reagents Firm for up to $2.9M Sep 21, 2012 In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec May 18, 2012 GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build Premium Apr 20, 2012 UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer Premium Jul 1, 2011 Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche Premium Jun 24, 2011 Roche, Evotec Partner on Protein Biomarkers for Cancer Drugs Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.